A detailed history of Distillate Capital Partners LLC transactions in Mckesson Corp stock. As of the latest transaction made, Distillate Capital Partners LLC holds 35,740 shares of MCK stock, worth $18.8 Million. This represents 1.13% of its overall portfolio holdings.

Number of Shares
35,740
Previous 28 127542.86%
Holding current value
$18.8 Million
Previous $15 Million 38.86%
% of portfolio
1.13%
Previous 2.52%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$518.81 - $607.81 $18.5 Million - $21.7 Million
35,712 Added 127542.86%
35,740 $20.9 Million
Q3 2023

Nov 14, 2023

SELL
$402.4 - $446.42 $804 - $892
-2 Reduced 6.67%
28 $12.2 Million
Q1 2023

May 12, 2023

BUY
$335.35 - $386.06 $335 - $386
1 Added 3.45%
30 $10.7 Million
Q4 2022

Feb 14, 2023

SELL
$346.68 - $397.58 $7.74 Million - $8.88 Million
-22,326 Reduced 99.87%
29 $10.9 Million
Q3 2022

Nov 09, 2022

SELL
$321.25 - $373.84 $977,563 - $1.14 Million
-3,043 Reduced 11.98%
22,355 $7.8 Million
Q2 2022

Aug 03, 2022

SELL
$300.57 - $336.42 $907,120 - $1.02 Million
-3,018 Reduced 10.62%
25,398 $8.29 Million
Q1 2022

May 11, 2022

BUY
$244.61 - $310.48 $414,613 - $526,263
1,695 Added 6.34%
28,416 $8.7 Million
Q4 2021

Feb 08, 2022

BUY
$198.21 - $248.9 $1.33 Million - $1.67 Million
6,709 Added 33.52%
26,721 $6.64 Million
Q3 2021

Nov 05, 2021

BUY
$188.42 - $208.66 $758,202 - $839,647
4,024 Added 25.17%
20,012 $3.99 Million
Q2 2021

Jul 30, 2021

BUY
$184.89 - $202.68 $93,184 - $102,150
504 Added 3.25%
15,988 $3.06 Million
Q1 2021

May 13, 2021

BUY
$169.52 - $196.53 $562,297 - $651,890
3,317 Added 27.26%
15,484 $3.02 Million
Q4 2020

Feb 12, 2021

BUY
$143.79 - $183.66 $1.75 Million - $2.23 Million
12,167 New
12,167 $2.11 Million

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $75.6B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track Distillate Capital Partners LLC Portfolio

Follow Distillate Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Distillate Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Distillate Capital Partners LLC with notifications on news.